GE HealthCare Technologies Inc.(GEHC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,225 of 2,961 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
GEHC Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for GE HealthCare Technologies Inc. (GEHC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores GEHC at 55.7/100 on a 32-signal composite quality model, placing it at rank #1,225 of 2,961 stocks — the top half of the AI-ranked universe. GEHC scores in the top quartile across revenue scale (92.8). Areas of concern include free cash flow (27.2) and revenue growth (37.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), GE HealthCare Technologies Inc. reports quarterly revenue of $5.1B, net income of $389.0M, an operating margin of 10.0%. Top institutional holders of GEHC by reported 13-F value include DODGE & COX, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. GEHC trades on the Nasdaq exchange and files with the SEC under CIK 1932393. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GEHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GE HealthCare Technologies Inc. directly from SEC EDGAR. GE HealthCare Technologies Inc.'s 13F Pro composite quality score has ranged between 54 and 64 since 2024, currently 55.7 — a declining long-term trajectory across 55 quarterly and live scoring snapshots.
Revenue
Q1 2026
$5.1B
Net Income
Q1 2026
$389.0M
Free Cash Flow
Q1 2026
$112.0M
Operating Margin
Q1 2026
10.0%
ROIC
Q1 2026
9.9%
D/E Ratio
Q1 2026
0.95
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+4.8% YoYNet Income
+4.6% YoYOperating Income
+5.3% YoYEPS (Diluted)
+4.8% YoYTotal Assets
+11.5% YoYTotal Debt
-7.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $20.63B +4.8% | $19.67B +0.6% | $19.55B +6.6% | $18.34B +4.3% | $17.59B | — |
| Net Income | $2.08B +4.6% | $1.99B +27.1% | $1.57B -18.2% | $1.92B -14.7% | $2.25B | — |
| Operating Income | $2.76B +5.3% | $2.63B +7.8% | $2.44B -3.4% | $2.52B -9.8% | $2.79B | — |
| EPS (Diluted) | $4.55 +4.8% | $4.34 +43.2% | $3.03 -28.2% | $4.22 -14.7% | $4.95 | — |
| Total Assets | $36.91B +11.5% | $33.09B +2.0% | $32.45B +17.8% | $27.54B | — | — |
| Total Debt | $11.01B -7.9% | $11.95B +4.4% | $11.45B +38.4% | $8.27B | — | — |
Get alerted when GEHC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for GE HealthCare Technologies Inc. including:
Top Institutional Holders of GEHC
DODGE & COX
$2.4B37,864,164 shBlackRock, Inc.
$2.4B37,467,843 shVANGUARD CAPITAL MANAGEMENT LLC
$1.9B29,724,359 shSTATE STREET CORP
$1.3B20,861,566 shVANGUARD PORTFOLIO MANAGEMENT LLC
$1.3B20,275,526 shInvesco Ltd.
$1.2B18,296,350 shHARRIS ASSOCIATES L P
$981.3M15,329,664 shBARROW HANLEY MEWHINNEY & STRAUSS LLC
$861.3M13,455,814 shGEODE CAPITAL MANAGEMENT, LLC
$820.8M12,871,800 shHOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
$784.2M12,250,502 sh
| Fund | Value | Shares |
|---|---|---|
| DODGE & COX | $2.4B | 37,864,164 |
| BlackRock, Inc. | $2.4B | 37,467,843 |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.9B | 29,724,359 |
| STATE STREET CORP | $1.3B | 20,861,566 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.3B | 20,275,526 |
| Invesco Ltd. | $1.2B | 18,296,350 |
| HARRIS ASSOCIATES L P | $981.3M | 15,329,664 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $861.3M | 13,455,814 |
| GEODE CAPITAL MANAGEMENT, LLC | $820.8M | 12,871,800 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $784.2M | 12,250,502 |
Companies Similar to GEHC
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Solstice Advanced Materials Inc.
CVS HEALTH Corp
Medtronic plc
LABCORP HOLDINGS INC.
ZIMMER BIOMET HOLDINGS, INC.
Viatris Inc
QUEST DIAGNOSTICS INC
ABBOTT LABORATORIES
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put GEHC on your watchlist
Track score changes the day GE HealthCare Technologies Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is GEHC a good stock to buy?
13F Pro's AI-powered analysis of GE HealthCare Technologies Inc. (GEHC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GEHC are available on the GEHC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. GEHC is classified as a large company.
Which hedge funds own GEHC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GEHC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of GE HealthCare Technologies Inc.'s investment landscape.